24 May 2013
Keywords: Dyax, Hereditary angioedema drug, Kalbitor, License, Sigma-Tau
Article | 22 June 2010
USA-based Dyax Corp has entered a strategic partnership with Defiante Farmaceutica, as subsidiary of Italian drugmaker Sigma-Tau, to develop and ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
22 June 2010
23 June 2010
21 June 2010
© 2013 thepharmaletter.com